Delivering Life-changing value
as a Global Specialty Pharmaceutical company
Welcome to Kyowa Kirin Global Corporate
Pursue advances in life sciences and technologiesDriven by state-of-the-art antibody technologies,
in the core therapeutic areas of nephrology, oncology,
immunology & allergy and neurologySee what we do
Our Financial Strategy for Creating Life-changing Value
Growth | September 9, 2021
Changes in society caused by COVID-19 and the impact on Kyowa Kirin
Growth | August 19, 2021
Bio Adventure Hands-On Experience Sessions: Become a drug discovery researcher During Your Summer Break
Sustainability | July 27, 2021
AMGEN AND KYOWA KIRIN TO JOINTLY DEVELOP AND COMMERCIALIZE KHK4083, A PHASE 3-READY, POTENTIAL FIRST-IN-CLASS TREATMENT FOR ATOPIC DERMATITIS
News Release | June 1, 2021
MEI Pharma and Kyowa Kirin Announce New Clinical Data on Zandelisib at American Society of Clinical Oncology Annual Meeting
News Release | May 20, 2021
White Paper on the unrecognized burden of XLH in adults in Europe
Patients | July 13, 2020
The Kyowa Kirin Group companies
contribute to the health and
well-being of people around
the world by
creating new value through the pursuit of
advances in life sciences and technologies.
Our goal is clear: to do everything we can to answer the
unmet medical needs of patients, their families, and
medical professionals, and to do it as quickly as possible.
Because every moment counts.
Our values are a way of thinking and attitude
that supports the activity of each officer and
employee belonging to the Kyowa Kirin
Group. It consists of core concept
"Commitment to Life" and three key words.
At a glance
Find out more about our company and our
to making positive contributions
in human health and
Kyowa Kirin Group companies are dedicated to
improving quality of life by answering
the unmet medical
needs of people worldwide.